Related Experiment Video
Updated: Dec 9, 2025

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma
Kartik Vasan1,2, Sunaina Anand3, Laveniya Satgunaseelan3
1Central Clinical School, University of Sydney, Sydney, Australia.
Background:
The treatment of advanced cutaneous head and neck cutaneous squamous cell carcinomas (HNcSCC) results in significant morbidity. Recently, immune checkpoint inhibitor treatment has been approved for DNA mismatch repair (MMR) deficient patients in a histology-agnostic manner. This study aims to evaluate the incidence of MMR deficiency in advanced HNcSCC and its association with clinicopathologic factors.
Methods:
The cohort included 176 consecutive HNcSCC cases treated with curative intent. Immunohistochemistry for MMR proteins (hMLH1, hMSH2, hMSH6, and hPMS2) was performed. Clinicopathological and survival data was collected prospectively.
Results:
The incidence of MMR protein deficiency was 9.1%. There was no association between age, incidence of metachronous malignancies, clinicopathological factors, or survival outcomes.
Conclusion:
A higher incidence of MMR deficiency was observed in this cohort of advanced HNcSCC. The lack of association with young age at onset or increased incidence of metachronous malignancies suggests that MMR deficiency is likely to be sporadic in HNcSCC.
Insights
The study found a 9.1% incidence of DNA mismatch repair (MMR) deficiency in advanced head and neck squamous cell carcinomas. This deficiency appears sporadic, with no link to patient age or other clinical factors.
Area of Science:
- Oncology
- Genetics
- Immunology
Background:
- Advanced cutaneous head and neck squamous cell carcinomas (HNcSCC) present significant treatment challenges.
- Immune checkpoint inhibitors are approved for DNA mismatch repair (MMR) deficient cancers.
- Understanding MMR deficiency in HNcSCC is crucial for treatment strategies.
Purpose of the Study:
- To determine the incidence of MMR deficiency in advanced HNcSCC.
- To investigate the association between MMR deficiency and clinicopathological factors.
- To assess the potential link between MMR deficiency and patient outcomes.
Main Methods:
- Immunohistochemistry was used to detect MMR protein expression (hMLH1, hMSH2, hMSH6, hPMS2).
- A cohort of 176 HNcSCC patients treated with curative intent was analyzed.
- Clinicopathological and survival data were collected prospectively.
Main Results:
- The incidence of MMR protein deficiency was 9.1% in the studied HNcSCC cohort.
- No significant association was found between MMR deficiency and patient age.
- MMR deficiency did not correlate with metachronous malignancies or survival outcomes.
Conclusions:
- Advanced HNcSCC exhibits a notable incidence of MMR deficiency.
- The sporadic nature of MMR deficiency in HNcSCC is suggested by the lack of association with early onset or metachronous malignancies.
- Further research may clarify the role of MMR deficiency in HNcSCC treatment response.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Long-patch Base Excision Repair

